SCHEMBL13072094

SCHEMBL13072094

NC(=O)[C@@H]1CCCN1C(=O)[C@H](CCCCC/C=C\[C@@H]1C[C@@H]1C(=O)NS(=O)(=O)C1CC1)Nc1cccc(F)c1

nearest known ligand 0.34

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
USP2 O75604 1/20 0.34
MEN1 O00255 1/20 0.33
KMT2A Q03164 1/20 0.33
ACE P12821 1/20 0.33
TACR1 P25103 1/20 0.33
NPSR1 Q6W5P4 2/20 0.33
SMN1; SMN2 Q16637 1/20 0.33
F2R P25116 1/20 0.32
TSHR P16473 1/20 0.32
OPRM1 P35372 1/20 0.32
F2 P00734 2/20 0.31
PRSS1 P07477 2/20 0.31
PRSS2 P07478 2/20 0.31
PRSS3 P35030 2/20 0.31
NR3C1 P04150 1/20 0.31
MAOA P21397 1/20 0.31
MAOB P27338 1/20 0.31
HTR1A P08908 1/20 0.31
HTR7 P34969 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13071524 0.92 HTR1A (0.36) KMT2AACEOPRM1F2PRSS1
SCHEMBL13071425 0.92 ACE (0.38) ACEOPRM1F2PRSS1PRSS2
SCHEMBL13071900 0.91 TACR1 (0.36) USP2MEN1KMT2AACETACR1
SCHEMBL13071521 0.90 CFD (0.39)
SCHEMBL13071403 0.90 USP2 (0.34) USP2MEN1KMT2AACETACR1
SCHEMBL13071393 0.89 DPP4 (0.32) F2R
SCHEMBL13072090 0.88 HTT (0.38) ACEF2PRSS1PRSS2PRSS3
SCHEMBL13071878 0.88 XIAP (0.34) ACEF2RF2PRSS1PRSS2
SCHEMBL13071668 0.88 ACE (0.33) ACEF2PRSS1PRSS2PRSS3
SCHEMBL13072089 0.87 F2R (0.33) ACEF2R

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2009142842-A9 NOVEL MACROCYCLIC INHIBITORS OF HEPATITIS C VIRUS REPLICATION INTERMUNE, INC. (US) 2010-11-25 WO disclosed
WO-2009142842-A2 NOVEL MACROCYCLIC INHIBITORS OF HEPATITIS C VIRUS REPLICATION INTERMUNE, INC. (US) 2009-11-26 WO disclosed